Sensible Biotechnologies is an mRNA platform company focused on revolutionizing mRNA manufacturing through a novel cell-based platform. They produce non-immunogenic, pure, and highly functional mRNA, addressing the limitations of traditional manufacturing methods. Their key products include long mRNA and naturally modified mRNA, which enhance the efficacy of mRNA therapies. The company aims to improve access to mRNA technology and strengthen biosecurity and supply chain resilience. With a strong team of experts in synthetic biology and biomanufacturing, Sensible is well-positioned in the growing mRNA therapeutics market.

Quality Assurance

Bratislava, Slovakia

Bratislava Region, Slovakia

Sensible Biotechnologies

BlueYard invests in founders with transforming ideas that decentralize markets, empower users and liberate data

BY Capital Management GmbH

BlueYard Capital

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Hello,
In 5 quick steps, tell us about the type of opportunities you'd be interested in next. We'll use this information to connect you to relevant opportunities in the BlueYard Capital network as they come up. You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a BlueYard Capital company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Explore open positions at BlueYard portfolio companies

Is this your company?